Navigation Links
IR BioSciences Announces Data Demonstrating Radilex Stimulation of,Stem Cells Results in Hematopoietic Recovery Following Lethal,Irradiation

ilex to address both the government market, as a countermeasure to radiological dispersion devices ("dirty bombs"), as well as the cancer market, as an adjuvant treatment candidate potentially ameliorating the side effects resulting from cancer radiotherapy.

"Recognizing our candidate product has this effect is very motivating. These results suggest a myriad of potential applications in which stem cell replenishment is clinically useful, and not just leukemias and lymphomas. We are excited about our research program and while focused on our current development plan, fully expect to broaden our understanding of the potential of Radilex based on upcoming and planned studies at Battelle and TGen" said ImmuneRegen CEO Michael Wilhelm.

Hollis-Eden and Cleveland BioLabs recently reported results on their respective radioprotectants in development. Hollis-Eden reported on the effects of NEUMUNE(R) (HE2100) in non-human primates exposed to 0.6 Gy total body irradiation and without clinical support such as antibiotics, IV fluids and platelet transfusions. They show an increase in survival in monkeys injected daily with NEUMUNE for 5 days despite severe neutropenia and thrombocytopenia. Of particular note, they find the platelet-restoring effect of their steroid to be most predictive of survival in treated animals. Studies carried out by Cleveland BioLabs have revealed the ability of their CBLB502 radioprotectant to protect non-human primates from the hematopoietic (as well as gastrointestinal) damage of gamma radiation. Also, their CBLB612 compound has been reported to increase bone marrow hematopoietic stem cells and enhance mobilization of these cells from bone marrow. They hypothesize that these cells are useful in repopulating irradiated animals with functionally competent hematopoietic components, thus enhancing survival following lethal doses of radiation.

ImmuneRegen has routinely utilized lethal total body radiation doses (7-9 Gy) in previously r
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
4. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
5. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
6. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
7. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
8. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
Post Your Comments:
(Date:6/17/2013)... Prime Therapeutics, in collaboration with public relations agency, ... the Silver Anvil for its internal communication campaign "Millions of ... at the Public Relations Society of America (PRSA) 2013 ... AXA Equitable Center in New York ... been presented annually since 1946, is the oldest and one ...
(Date:6/17/2013)... June 17, 2013 /PRNewswire-iReach/ -- Weiler Labeling Systems, ... X-4S pressure sensitive labeling head. The X-4S is ... performance requirements that serialization demands. ... uniquely qualified to work with pharmaceutical and medical ... and track and trace implementation strategies. Designed for ...
(Date:6/17/2013)... WORCESTER, Mass. and TORONTO ... www.generex.com ) (OTCBB:GNBT) today announced that it entered into ... June 17, 2013.  The investors have agreed to purchase ... of the Company,s newly designated non-voting Series E 9% ... purchase up to an aggregate of 100% of the ...
Breaking Medicine Technology:Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America 2Weiler Labeling Introduces Serialization-Capable X-4S Labeling Head 2Generex Announces $1,225,000 Capital Investment 2Generex Announces $1,225,000 Capital Investment 3Generex Announces $1,225,000 Capital Investment 4Generex Announces $1,225,000 Capital Investment 5
(Date:6/18/2013)... that cancer cells have a much different and ... at The University of Texas at Dallas have found ... to combat lung cancer. , In an article published ... , UT Dallas researchers compared the metabolic characteristics of ... from the same patient. , They found that ...
(Date:6/18/2013)... June 18, 2013 The July 2013 issue ... Guide to Getting Beach Ready,” offers a list of home ... their best in a bathing suit this summer. The list ... firming , smoothing cellulite , and more. (go to ... Medical Director of Epione Beverly Hills, “though I would say ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 A new ... storm. The burgeoning aquaculture industry is redefining the way ... of the most acclaimed personal culinary chefs on the ... on benefits of sustainable seafood and the promising industry ... abundance these days. Many consumers strive to fully partake ...
(Date:6/18/2013)... By studying one of the most successful ... of successful strategies in his article What We Can ... Study. , The inspirational brand Gollan refers to is ... an impressive 62 million followers (and rising). , The ... Facebook Pages earlier this year. The Facebook data tracking publication ...
(Date:6/18/2013)... President Obama officially declared June as Lesbian, ... However, despite advances in civil rights, sexual ... for suicide than their heterosexual peers, according ... University of Missouri psychology graduate student recently ... sexual minority youth, which could help improve ...
Breaking Medicine News(10 mins):Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Skin Care – Getting Your Body Beach Ready 2Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 3Health News:Sexual minority youth need specialized treatment from therapists 2
... - Reiterates 2008 Revenue Guidance of $50 Million, ... DIET ), leveraging the power of the Internet to ... announced,results for the quarter and twelve months ended December ... fourth quarter of 2007 were,$6.9 million, compared to $9.5 ...
... cheap drugs are less effective, researchers find , , TUESDAY, ... medication is expensive, they tend to report more benefit than ... finds. , In fact, 85 percent of people given ... reduction in pain, compared with 61 percent of those given ...
... Governor Edward G.,Rendell,s health care team today ... Governor,s Cover All Pennsylvanians continues to grow and, ... and tobacco products, there are,funds to pay for ... the team told the House of Representatives Appropriations,Committee ...
... Strategies and Lessons Learned in Building a Unified, ... What is essential to,developing a successful, integrated cardiovascular ... help you develop a,project strategy that sets proper ... same page? What tools will help you unify ...
... finds little difference in effectiveness of 5 drugs currently ... no proof that any one of the five drugs ... better than the others, says an American College of ... committee that just issued a new guideline on drug ...
... prevalence of adverse drug reactions in the treatment of ... than their male counterparts to be treated with statins, ... researchers at Rush University Medical Center. The study is ... Medicine. , Developments in disease recognition and novel treatment ...
Cached Medicine News:Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 2Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 3Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 4Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 5Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 6Health News:eDiets.com(R) Announces Q4 and Year End 2007 Results 7Health News:Price Plays Part in Perceived Power of Medication 2Health News:Price Plays Part in Perceived Power of Medication 3Health News:Governor Rendell's Health Care Reform Cabinet Says Providing Access to Health Care for Pennsylvania's Uninsured is Within Reach 2Health News:Governor Rendell's Health Care Reform Cabinet Says Providing Access to Health Care for Pennsylvania's Uninsured is Within Reach 3Health News:Governor Rendell's Health Care Reform Cabinet Says Providing Access to Health Care for Pennsylvania's Uninsured is Within Reach 4Health News:Achieving CVIS Goals Webinar 2Health News:Groups Issue New Dementia Drug Guidelines 2Health News:Women are treated less frequently than men with statins, aspirin and beta-blockers 2
... percutaneous placement of a pigtail ... for nephrostomy drainage in neonatal ... in peel-open packages. Intended for ... is advised; catheter must not ...
... BioPlex 2200 system is a fully ... can deliver up to 2200 results ... include a panel of assays targeting ... are in the areas of serology, ...
... and a FAM-labeled probe targeting the glycoprotein D ... primers and an Alexa 532-labeled probe designed to ... 2. This ASR requires an instrument that can ... like the Cepheid SmartCycler System. The Cepheid Analyte ...
... The HSV Non-Typing ASR contains primers and ... a 92 bp region of the HSV Type ... requires an instrument that can detect a FAM ... The Cepheid Analyte Specific Reagent* (ASR) program is ...
Medicine Products: